Pulse Biosciences, Inc. financial data

Symbol
PLSE on Nasdaq
Location
3957 Point Eden Way, Hayward, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.28K % +85.3%
Debt-to-equity 14.9 % -56.6%
Return On Equity -65.3 % +40.8%
Return On Assets -56.8 % +30.8%
Operating Margin 442K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 67.3M shares +9.77%
Common Stock, Shares, Outstanding 67.3M shares +21.8%
Entity Public Float 183M USD +47.5%
Common Stock, Value, Issued 67K USD +21.8%
Weighted Average Number of Shares Outstanding, Basic 67.3M shares +17.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
Cost of Revenue 0 USD -100%
Research and Development Expense 40.8M USD +39.4%
General and Administrative Expense 31.5M USD +86.4%
Costs and Expenses 72.2M USD +56.6%
Operating Income (Loss) -72.2M USD -56.6%
Nonoperating Income (Expense) 4.21M USD +99.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -68M USD -54.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -68M USD -54.5%
Earnings Per Share, Basic -1 USD/shares -42.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 106M USD +306%
Inventory, Net 51K USD
Assets, Current 108M USD +297%
Property, Plant and Equipment, Net 1.11M USD -15.5%
Operating Lease, Right-of-Use Asset 6.61M USD -3.1%
Goodwill 2.79M USD 0%
Other Assets, Noncurrent 677K USD -5.18%
Assets 120M USD +197%
Accounts Payable, Current 2.74M USD +67.5%
Employee-related Liabilities, Current 3.47M USD +29.7%
Accrued Liabilities, Current 4.78M USD +50.3%
Contract with Customer, Liability, Current 4K USD -75%
Liabilities, Current 8.98M USD +50.6%
Operating Lease, Liability, Noncurrent 6.79M USD -9.48%
Liabilities 15.8M USD +17.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -426M USD -19%
Stockholders' Equity Attributable to Parent 104M USD +287%
Liabilities and Equity 120M USD +197%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.5M USD -38.3%
Net Cash Provided by (Used in) Financing Activities 14.8M USD +4755%
Net Cash Provided by (Used in) Investing Activities -45K USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 67.3M shares +21.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.24M USD
Deferred Tax Assets, Valuation Allowance 99.5M USD +13.3%
Deferred Tax Assets, Gross 101M USD +13%
Operating Lease, Liability 8.25M USD -4.61%
Depreciation 497K USD -7.79%
Payments to Acquire Property, Plant, and Equipment 45K USD +800%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -68M USD -54.5%
Lessee, Operating Lease, Liability, to be Paid 10.1M USD -9.3%
Property, Plant and Equipment, Gross 5.3M USD +4.87%
Operating Lease, Liability, Current 1.46M USD +27.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.3M USD +12.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.23M USD +12.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.9M USD -25.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.38M USD +12.5%
Deferred Tax Assets, Operating Loss Carryforwards 67M USD +9.63%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 17.4M USD +70.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.08M USD
Operating Lease, Payments 533K USD +13.6%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 166K USD -0.6%
Deferred Tax Assets, Net of Valuation Allowance 1.6M USD -3.33%
Share-based Payment Arrangement, Expense 20.6M USD +131%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%